Severe ketoacidosis in a patient taking SGLT2 inhibitor for diabetes

被引：0
|
作者：
Hatlen, Kristine Vaage [1 ]
Sharma, Archana [1 ]
Nermoen, Ingrid [1 ,2 ]
机构：
[1] Akershus Univ Sykehus, Endokrinol Avdeling, Nordbyhagen, Norway
[2] Univ Oslo, Inst Klin Med, Oslo, Norway
来源：
TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING | 2020年 / 140卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1267 / 1269
页数：3
相关论文
共 50 条
  • [41] SGLT2 Inhibitor-Induced Euglycemic Ketoacidosis in a Non-Diabetic Patient with Ischemic Cardiomyopathy
    Khadka, Sulochana
    Rajak, Kripa
    Matai, Pallavi
    Timilsina, Bibek
    Sharma, Seema
    Halder, Anupam
    Martinez, Evelyn Calderon
    Jaiswal, Vikash
    CIRCULATION, 2024, 150
  • [42] IMPROVEMENT OF PSORIASIS AND CHRONIC ERUPTION AFTER TAKING SGLT2 INHIBITOR: IPRAGLIFLOZIN IN DIABETES OF JAPANESE
    Suzuki, Y.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S266 - S266
  • [43] SGLT2 inhibitors increase risk for diabetic ketoacidosis in type 2 diabetes
    Griffin, Tomas P.
    Dinneen, Sean F.
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (08) : JC40 - JC40
  • [44] SGLT2 Inhibitors in Type 2 Diabetes: comparatively higher Risk of Ketoacidosis
    Dobler, Gabriele
    DIABETOLOGIE UND STOFFWECHSEL, 2022, 17 (04) : 240 - 240
  • [45] Ketonemia Promoted by an SGLT2 Inhibitor in a Patient with Hyperthyroidism
    Shimodaira, Masanori
    Nakajima, Sadao
    CANADIAN JOURNAL OF DIABETES, 2017, 41 (05) : 476 - 477
  • [46] Influence on urination of SGLT2 inhibitor in type 2 diabetes
    Sasaki, Junko
    Shikuma, Junpei
    Ito, Rokuro
    Odawara, Masato
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S98 - S98
  • [47] SGLT2 inhibitor shows promise in type 2 diabetes
    Nature Reviews Drug Discovery, 2010, 9 (3) : 182 - 182
  • [48] DAPAGLIFLOZIN, AN SGLT2 INHIBITOR FOR THE TREATMENT OF TYPE 2 DIABETES
    Demaris, K. M.
    White, J. R.
    DRUGS OF TODAY, 2013, 49 (05) : 289 - 301
  • [49] Clinical Outcomes of Diabetic Ketoacidosis in Type 2 Diabetes Patients with and without SGLT2 Inhibitor Treatment: A Retrospective Study
    Nakhleh, Afif
    Othman, Areen
    Masri, Amin
    Zloczower, Moshe
    Zolotov, Sagit
    Shehadeh, Naim
    BIOMEDICINES, 2023, 11 (10)
  • [50] Acid-base changes during diabetic ketoacidosis in type 1 diabetes with/without SGLT2 inhibitor
    Mursic, I.
    Svehlikova, E.
    Regittnig, W.
    Urschitz, M.
    Wolf, M.
    Brunner, M.
    Augustin, T.
    Magnes, C.
    Eberl, A.
    Heise, T.
    Klein, O.
    Sourij, H.
    Pieber, T.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S272 - S273
12345